Phytosomes Loaded with Mastoparan-M Represent a Novel Strategy for Breast Cancer Treatment
Phy-Mast-M demonstrates significant anti-tumor activity both in vitro and in vivo. Moreover, its potential for clinical translation suggests promising prospects for cancer therapy, offering more drug options for breast cancer patients.
Authors
- Ruiqin Yang
- Qingmo Yang (ORCID: https://orcid.org/0000-0002-6904-9772)
- Chaojie Liu (ORCID: https://orcid.org/0000-0003-0877-0424)
- Hairong Zhao (ORCID: https://orcid.org/0000-0003-0000-8136)
- Ya-Ting Gai
- Shuanglong Chen (ORCID: https://orcid.org/0000-0003-0533-4336)
- Kangliang Lou (ORCID: https://orcid.org/0000-0001-5465-8244)
- Chenggui Zhang (ORCID: https://orcid.org/0000-0002-2691-5079)
- Heng Liu (ORCID: https://orcid.org/0000-0002-1238-0683)
- Jinyan Lin (ORCID: https://orcid.org/0000-0002-9730-3643)
- Shuangyan Bao
Institutions
- Xiamen University (CN)
- First Affiliated Hospital of Xiamen University (CN)
- Shandong Institute of Food and Drug Inspection (CN)
- Dali University (CN)
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.2147/ijn.s481871
- Citations
- 8
- Primary Topic
- Healthcare and Venom Research
- Type
- article
- Field-Weighted Citation Impact
- 11.16
Funders
- Natural Science Foundation of Xiamen City
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- Fujian Provincial Health Commission